# HCRTR2

## Overview
The HCRTR2 gene encodes the hypocretin receptor 2, a G protein-coupled receptor (GPCR) that plays a pivotal role in the regulation of sleep and arousal. This receptor is part of the orexin system, binding the neuropeptides hypocretin-1 and hypocretin-2, also known as orexin A and B, respectively. Hypocretin receptor 2 is predominantly expressed in the brain, particularly in regions such as the hypothalamus, where it is integral to maintaining wakefulness and energy homeostasis. The receptor's function is mediated through its interaction with various G-proteins, which transduce extracellular signals into intracellular responses, influencing processes such as neurotransmitter release and neuronal excitation. Dysfunctions in HCRTR2 signaling have been implicated in sleep disorders like narcolepsy, as well as in certain neurological and psychiatric conditions, highlighting its clinical significance (Sutcliffe2000The; Li2020The).

## Structure
The HCRTR2 gene encodes the hypocretin receptor 2, a G protein-coupled receptor (GPCR) involved in sleep regulation and arousal. This receptor is characterized by a conserved structural organization featuring seven transmembrane helices, which is typical of GPCRs (Fonin2019Multifunctionality). The transmembrane helices form a three-dimensional structure that includes a ligand-binding cleft, which is partially hydrophilic and partially hydrophobic, allowing for the binding of orexin peptides (Thompson2014OX1).

The receptor's intracellular loops and C-terminus are crucial for coupling with multiple G proteins, such as Gi, Go, Gs, and Gq, influencing receptor interaction with effectors (Thompson2014OX1). Post-translational modifications, including glycosylation and phosphorylation, are important for the receptor's function and signaling, affecting aspects like receptor internalization and degradation (Thompson2014OX1).

While specific details on the primary, tertiary, and quaternary structures of HCRTR2 are not provided, the receptor's structural flexibility and potential for dimerization are noted, although evidence for dimerization in native cells is lacking (Thompson2014OX1). The receptor's structural dynamics contribute to its ability to interact with various intracellular proteins and engage in biased signaling (Fonin2019Multifunctionality).

## Function
The HCRTR2 gene encodes the hypocretin receptor 2, a G-protein-coupled receptor that binds the neuropeptides hypocretin-1 and hypocretin-2, also known as orexin A and B. This receptor is primarily involved in the regulation of wakefulness, arousal, and energy homeostasis. HCRTR2 is highly expressed in the brain, particularly in regions such as the hypothalamus, cerebral cortex, and hippocampus, where it plays a crucial role in maintaining wakefulness and regulating sleep-wake cycles (Sutcliffe2000The; Li2020The).

At the molecular level, HCRTR2 mediates its effects by transducing extracellular signals into intracellular responses through G-proteins. This signaling pathway involves the activation of calcium channels and protein kinase C, which are essential for neurotransmitter release and neuronal excitation (Sutcliffe2000The; Shiba2002Hypocretin). The receptor's activity is crucial for the modulation of various physiological processes, including feeding behavior, autonomic functions, and neuroendocrine regulation (Li2020The).

HCRTR2's role in sleep regulation is underscored by its involvement in narcolepsy, a disorder characterized by excessive daytime sleepiness and cataplexy, often linked to dysfunctions in hypocretin signaling (Sutcliffe2000The). The receptor's function in healthy human cells is vital for maintaining normal sleep patterns and energy balance.

## Clinical Significance
Mutations and polymorphisms in the HCRTR2 gene have been associated with several neurological and psychiatric conditions. The G1246A polymorphism in the HCRTR2 gene is linked to an increased risk of cluster headaches (CH), a severe headache disorder characterized by unilateral pain and cranial autonomic symptoms. Studies have shown that carriers of the GG genotype have a higher risk of developing CH compared to other genotypes (Rainero2007Association; Schürks2006Cluster; Papasavva2019Analysis). However, some studies have not found a significant association, indicating potential genetic heterogeneity (Baumber2006A).

The HCRTR2 gene is also implicated in sleep disorders, particularly narcolepsy. Although no common mutations in HCRTR2 have been found in most human narcolepsy cases, the gene is involved in the regulation of the sleep-wake cycle, and its dysfunction may contribute to the disorder (Peyron2000A).

In psychiatric conditions, the HCRTR2-Val308Iso polymorphism has been associated with panic disorder, especially in female patients (Annerbrink2011Panic). Alterations in HCRTR2 expression or function have also been linked to depression-like behaviors, with HCRTR2-null mice exhibiting increased behavioral despair (Scott2011Hcrtr1).

## Interactions
HCRTR2, or hypocretin receptor 2, is a G-protein-coupled receptor that primarily interacts with G-proteins to mediate its signaling functions. The receptor is known to bind both hypocretin-1 and hypocretin-2 peptides with high affinity, leading to the activation of G-proteins. This interaction is crucial for the receptor's role in promoting wakefulness and regulating sleep-wake cycles (Shiba2002Hypocretin).

In transfected cell lines, HCRTR2 has been shown to stimulate [35S]GTPγS binding, indicating a receptor-mediated interaction with G-proteins. This interaction is concentration-dependent and can be reversed by hypocretin receptor antagonists, confirming the role of HCRTR2 in G-protein signaling pathways (Shiba2002Hypocretin). The receptor's interaction with G-proteins is also evident in brain homogenates, where hypocretin-stimulated [35S]GTPγS binding is observed, although with regional differences in binding levels (Shiba2002Hypocretin).

In the rat pontine reticular formation, HCRTR2, along with HCRTR1, modulates acetylcholine release by coupling to both inhibitory and stimulatory G-proteins. This dual coupling suggests that HCRTR2 can engage in complex signaling pathways that influence neurotransmitter release and arousal states (Bernard2005Hypocretin).


## References


[1. (Thompson2014OX1) Miles D. Thompson, Henri Xhaard, Takeshi Sakurai, Innocenzo Rainero, and Jyrki P. Kukkonen. Ox1 and ox2 orexin/hypocretin receptor pharmacogenetics. Frontiers in Neuroscience, May 2014. URL: http://dx.doi.org/10.3389/fnins.2014.00057, doi:10.3389/fnins.2014.00057. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnins.2014.00057)

[2. (Fonin2019Multifunctionality) Alexander V. Fonin, April L. Darling, Irina M. Kuznetsova, Konstantin K. Turoverov, and Vladimir N. Uversky. Multi-functionality of proteins involved in gpcr and g protein signaling: making sense of structure–function continuum with intrinsic disorder-based proteoforms. Cellular and Molecular Life Sciences, 76(22):4461–4492, August 2019. URL: http://dx.doi.org/10.1007/s00018-019-03276-1, doi:10.1007/s00018-019-03276-1. This article has 50 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-019-03276-1)

[3. (Li2020The) Shi-Bin Li and Luis de Lecea. The hypocretin (orexin) system: from a neural circuitry perspective. Neuropharmacology, 167:107993, May 2020. URL: http://dx.doi.org/10.1016/j.neuropharm.2020.107993, doi:10.1016/j.neuropharm.2020.107993. This article has 94 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.neuropharm.2020.107993)

[4. (Scott2011Hcrtr1) Michael M. Scott, Jacob N. Marcus, Ami Pettersen, Shari G. Birnbaum, Takatoshi Mochizuki, Thomas E. Scammell, Eric J. Nestler, Joel K. Elmquist, and Michael Lutter. Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. Behavioural Brain Research, 222(2):289–294, September 2011. URL: http://dx.doi.org/10.1016/j.bbr.2011.02.044, doi:10.1016/j.bbr.2011.02.044. This article has 103 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbr.2011.02.044)

[5. (Bernard2005Hypocretin) René Bernard, Ralph Lydic, and Helen A. Baghdoyan. Hypocretin (orexin) receptor subtypes differentially enhance acetylcholine release and activate g protein subtypes in rat pontine reticular formation. Journal of Pharmacology and Experimental Therapeutics, 317(1):163–171, December 2005. URL: http://dx.doi.org/10.1124/jpet.105.097071, doi:10.1124/jpet.105.097071. This article has 30 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1124/jpet.105.097071)

[6. (Sutcliffe2000The) J. Gregor Sutcliffe and Luis de Lecea. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. Journal of Neuroscience Research, 62(2):161–168, 2000. URL: http://dx.doi.org/10.1002/1097-4547(20001015)62:2<161::AID-JNR1>3.0.CO;2-1, doi:10.1002/1097-4547(20001015)62:2<161::aid-jnr1>3.0.co;2-1. This article has 270 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/1097-4547(20001015)62:2)

[7. (Schürks2006Cluster) M. Schürks, T. Kurth, I. Geissler, G. Tessmann, H. -C. Diener, and D. Rosskopf. Cluster headache is associated with the g1246a polymorphism in the hypocretin receptor 2 gene. Neurology, 66(12):1917–1919, June 2006. URL: http://dx.doi.org/10.1212/01.wnl.0000215852.35329.34, doi:10.1212/01.wnl.0000215852.35329.34. This article has 75 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1212/01.wnl.0000215852.35329.34)

[8. (Annerbrink2011Panic) Kristina Annerbrink, Lars Westberg, Marie Olsson, Sven Andersch, Ingemar Sjödin, Göran Holm, Christer Allgulander, and Elias Eriksson. Panic disorder is associated with the val308iso polymorphism in the hypocretin receptor gene. Psychiatric Genetics, 21(2):85–89, April 2011. URL: http://dx.doi.org/10.1097/ypg.0b013e328341a3db, doi:10.1097/ypg.0b013e328341a3db. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/ypg.0b013e328341a3db)

[9. (Peyron2000A) Christelle Peyron, Juliette Faraco, William Rogers, Beth Ripley, Sebastiaan Overeem, Yves Charnay, Sona Nevsimalova, Michael Aldrich, David Reynolds, Roger Albin, Robin Li, Marcel Hungs, Mario Pedrazzoli, Muralidhara Padigaru, Melanie Kucherlapati, Jun Fan, Richard Maki, Gert Jan Lammers, Constantin Bouras, Raju Kucherlapati, Seiji Nishino, and Emmanuel Mignot. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nature Medicine, 6(9):991–997, September 2000. URL: http://dx.doi.org/10.1038/79690, doi:10.1038/79690. This article has 1630 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/79690)

[10. (Rainero2007Association) Innocenzo Rainero, Elisa Rubino, Walter Valfrè, Salvatore Gallone, Paola De Martino, Erika Zampella, and Lorenzo Pinessi. Association between the g1246a polymorphism of the hypocretin receptor 2 gene and cluster headache: a meta-analysis. The Journal of Headache and Pain, 8(3):152–156, June 2007. URL: http://dx.doi.org/10.1007/s10194-007-0383-x, doi:10.1007/s10194-007-0383-x. This article has 45 citations.](https://doi.org/10.1007/s10194-007-0383-x)

[11. (Baumber2006A) L. Baumber, C. Sjöstrand, M. Leone, H. Harty, G. Bussone, J. Hillert, R. C. Trembath, and M. B. Russell. A genome-wide scan and hcrtr2 candidate gene analysis in a european cluster headache cohort. Neurology, 66(12):1888–1893, June 2006. URL: http://dx.doi.org/10.1212/01.wnl.0000219765.95038.d7, doi:10.1212/01.wnl.0000219765.95038.d7. This article has 73 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1212/01.wnl.0000219765.95038.d7)

[12. (Shiba2002Hypocretin) T Shiba, M Ozu, Y Yoshida, E Mignot, and S Nishino. Hypocretin stimulates [35s]gtpγs binding in hcrtr 2-transfected cell lines and in brain homogenate. Biochemical and Biophysical Research Communications, 294(3):615–620, June 2002. URL: http://dx.doi.org/10.1016/s0006-291x(02)00521-1, doi:10.1016/s0006-291x(02)00521-1. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0006-291x(02)00521-1)

[13. (Papasavva2019Analysis) Maria Papasavva, Martha-Spyridoula Katsarou, Michail Vikelis, Euthymia Mitropoulou, Emmanouil V. Dermitzakis, Stylianos Papakonstantinou, Chryssa Arvaniti, Dimos-Dimitrios Mitsikostas, Illana Gozes, Aristides M. Tsatsakis, and Nikolaos Drakoulis. Analysis of hcrtr2, gnb3, and adh4 gene polymorphisms in a southeastern european caucasian cluster headache population. Journal of Molecular Neuroscience, 70(3):467–474, November 2019. URL: http://dx.doi.org/10.1007/s12031-019-01439-0, doi:10.1007/s12031-019-01439-0. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12031-019-01439-0)